Ankaferd Blood Stopper for controlling gastrointestinal bleeding due to distinct benign lesions refractory to conventional antihemorrhagic measures


Kurt M., Onal I. K. , Akdogan M., Kekilli M., Arhan M., Sayilir A., ...More

CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, vol.24, no.6, pp.380-384, 2010 (Journal Indexed in SCI) identifier identifier

  • Publication Type: Article / Article
  • Volume: 24 Issue: 6
  • Publication Date: 2010
  • Doi Number: 10.1155/2010/896819
  • Title of Journal : CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
  • Page Numbers: pp.380-384

Abstract

OBJECTIVE: To assess the hemostatic efficacy of the Ankaferd Blood Stopper (ABS, Ankaferd Health Products Ltd, Turkey) hemostatic agent for controlling gastrointestinal bleeding associated with various benign lesions refractory to conventional antihemorrhagic measures.